• Search
  • Login
  • Register
Menu
  • BJH
  • Home
  • News
  • CongressUpdate
  • Guidelines
  • Specials
  • Links
All
  • All
  • BJH articles
  • Blog articles
  • Specials
Forgot Password? Not a member yet? Register here
  • Ivosidenib plus azacitidine for patients with IDH1-mutated acute myeloid leukaemia

  • Zanubrutinib as a new treatment option for patients with Waldenström macroglobulinaemia

  • FDA approval for brentuximab vedotin for children with high-risk Hodgkin lymphoma

Recommended

Science

Amsterdam scientists investigate why immunotherapy fails in Chronic Lymphocytic Leukaemia

Pharma News

INREBIC® (FEDRATINIB) NOW REIMBURSED FOR PATIENTS WITH MYELOFIBROSIS

Clinical trials

Rondaptivon pegol can be used as a treatment for severe and nonsevere haemophilia A

subscribe Latest issue All issues Newsletters
Index latest issue
  • Highlights in chronic lymphocytic leukaemia
  • Highlights in chronic myeloid leukaemia
  • Highlights in lymphoma
  • Long-term outcomes of isatuximab in high-risk multiple myeloma
  • Highlights in multiple myeloma
  • Navigating secondary acute myeloid leukaemia in 2023
  • Highlights in acute myeloid leukaemia and myelodysplastic syndromes
  • Highlights in acute lymphoblastic leukaemia
  • New haematology reimbursements in Belgium
Clinical practice

High-frequency vincristine-steroid pulses do not benefit outcomes in acute lymphoblastic leuka...

Health Innovation

Wearable device for tracking temperature of paediatric blood cancer patients at home

Clinical trials

Axi-cel as an effective second-line treatment for R/R LBCL patients ineligible for transplanta...

Prevention

Safety and efficacy of the BNT162b mRNA COVID-19 vaccine in patients with chronic lymphocytic ...

Cancer-associated thrombosis awareness survey (ECPC)

Show me

Also interesting

Science

Canakinumab in children and young adults with sickle cell anaemia

Clinical practice

Long-term remission rates after treatment with tisagenlecleucel in paediatric and young adult ...

Clinical trials

Encouraging results with loncastuximab tesirine plus rituximab for DLBCL patients

Health Innovation

New Danish app helps doctors in making better decisions for leukaemia patients

Top

Join our newsletter

  • This field is for validation purposes and should be left unchanged.
  • About BJH
  • Advertisements & sponsoring
  • Vacancies
  • Disclaimer
  • Privacy
  • Contact

BJH is published by Ariez International BV, Westzijde 22, 1506 EE Zaandam, The Netherlands

© BJH 2023